These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 25783855)

  • 1. Enhancing the bioavailability of mebendazole by integrating the principles solid dispersion and nanocrystal techniques, for safe and effective management of human echinococcosis.
    Chaudhary S; Garg T; Rath G; Murthy RR; Goyal AK
    Artif Cells Nanomed Biotechnol; 2016 May; 44(3):937-42. PubMed ID: 25783855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of dissolution and bioavailability for mebendazole, an agent for human echinococcosis, by preparing solid dispersion with polyethylene glycol.
    Chiba Y; Kohri N; Iseki K; Miyazaki K
    Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2158-60. PubMed ID: 1797442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An alternative mebendazole formulation for cystic echinococcosis: the treatment efficacy, pharmacokinetics and safety in mice.
    Liu CS; Zhang HB; Lei W; Zhang CW; Jiang B; Zheng Q; Yin JH; Han XM
    Parasit Vectors; 2014 Dec; 7():589. PubMed ID: 25491386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changed crystallinity of mebendazole solid dispersion: improved anthelmintic activity.
    García-Rodriguez JJ; de la Torre-Iglesias PM; Vegas-Sánchez MC; Torrado-Durán S; Bolás-Fernández F; Torrado-Santiago S
    Int J Pharm; 2011 Jan; 403(1-2):23-8. PubMed ID: 20934497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental chemotherapy of alveolar hydatid disease. 12. The efficacy of drug forms of mebendazole and nocodazole with high bioavailability].
    Dzhabarova VI; Dobrotvorskiĭ AE; Krotov AI
    Med Parazitol (Mosk); 1989; (5):43-6. PubMed ID: 2615711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose.
    de la Torre-Iglesias PM; García-Rodriguez JJ; Torrado G; Torrado S; Torrado-Santiago S; Bolás-Fernández F
    Drug Des Devel Ther; 2014; 8():1467-79. PubMed ID: 25258515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.
    Ha ES; Kim JS; Baek IH; Yoo JW; Jung Y; Moon HR; Kim MS
    Drug Des Devel Ther; 2015; 9():4269-77. PubMed ID: 26345723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical trial of the possibility of increasing the bioavailability of mebendazole using sunflower oil in echinococcosis].
    Shcherbakov AM; Lur'e AA
    Med Parazitol (Mosk); 1989; (3):46-9. PubMed ID: 2674643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced bioavailability and cysticidal effect of three mebendazole-oil preparations in mice infected with secondary cysts of Echinococcus granulosus.
    Liu CS; Zhang HB; Jiang B; Yao JM; Tao Y; Xue J; Wen AD
    Parasitol Res; 2012 Sep; 111(3):1205-11. PubMed ID: 22661241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research progress on the efficacy, metabolism and bioavailability of mebendazole in hydatid disease].
    Liu CS; Zhang HB
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Dec; 27(6):513-9. PubMed ID: 20232637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The enhanced bioavailability of mebendazole in echinococcosis patients when used with Essentiale].
    Shcherbakov AM; Lur'e AA
    Med Parazitol (Mosk); 1993; (1):43-5. PubMed ID: 8336653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability.
    Onoue S; Takahashi H; Kawabata Y; Seto Y; Hatanaka J; Timmermann B; Yamada S
    J Pharm Sci; 2010 Apr; 99(4):1871-81. PubMed ID: 19827133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
    Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
    Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation.
    Jiang T; Han N; Zhao B; Xie Y; Wang S
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1230-9. PubMed ID: 22229827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations.
    Law D; Schmitt EA; Marsh KC; Everitt EA; Wang W; Fort JJ; Krill SL; Qiu Y
    J Pharm Sci; 2004 Mar; 93(3):563-70. PubMed ID: 14762895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clopidogrel Napadisilate Monohydrate Loaded Surface-Modified Solid Dispersion: Physicochemical Characterization and in Vivo Evaluation.
    Kim YH; Kim DW; Kwon MS; Cho KH; Kim JO; Yong CS; Choi HG
    Biol Pharm Bull; 2015; 38(7):1033-40. PubMed ID: 26133713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental therapy of echinococcosis. 1. Laboratory model of echinococcosis and the effect of sarcolysinacridine, levamisole and mebendazole on the development of larval cysts of Echinococcus granulosus].
    Kovalenko FP; Krotov AI; Budanova IS; Razakov ShA
    Med Parazitol (Mosk); 1976; 45(5):546-51. PubMed ID: 1025460
    [No Abstract]   [Full Text] [Related]  

  • 18. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.
    Yun F; Kang A; Shan J; Zhao X; Bi X; Li J; Di L
    Int J Pharm; 2014 Apr; 465(1-2):436-43. PubMed ID: 24576810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical and biopharmaceutical characterization of amorphous solid dispersion of nobiletin, a citrus polymethoxylated flavone, with improved hepatoprotective effects.
    Onoue S; Nakamura T; Uchida A; Ogawa K; Yuminoki K; Hashimoto N; Hiza A; Tsukaguchi Y; Asakawa T; Kan T; Yamada S
    Eur J Pharm Sci; 2013 Jul; 49(4):453-60. PubMed ID: 23707470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of X-ray powder diffraction and solid-state nuclear magnetic resonance in estimating crystalline fraction of tacrolimus in sustained-release amorphous solid dispersion and development of discriminating dissolution method.
    Rahman Z; Bykadi S; Siddiqui A; Khan MA
    J Pharm Sci; 2015 May; 104(5):1777-86. PubMed ID: 25753829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.